Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
FH
REST API REST API
Homo sapiens
FH is differentially expressed in 320 experiments: 141 organism parts: liver, bone marrow, ... (139 more);, 250 disease states: normal, lung adenocarcinoma, ... (248 more);, 103 cell types 453 cell lines 37 compound treatments and 87 other conditions.
Synonyms fumarase
Orthologs F6Z761_CIOIN (Ciona intestinalis)   Q5ZLD1_CHICK (Gallus gallus)   Fh1 (Mus musculus)   FUM1 (Saccharomyces cerevisiae)   fh (Danio rerio)   Q148D3_BOVIN (Bos taurus)   Fh1 (Rattus norvegicus)   CG31874 (Drosophila melanogaster)   l(1)G0255 (Drosophila melanogaster)   CG6140 (Drosophila melanogaster)   CG4095 (Drosophila melanogaster)   LOC100491219 (Xenopus laevis)   FH (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cytoplasm, malate metabolic process, mitochondrial matrix, cell junction, fumarate metabolic process, lyase activity, tricarboxylic acid cycle enzyme complex, tricarboxylic acid cycle, fumarate hydratase activity, mitochondrion, homeostasis of number of cells within a tissue
InterPro Term Fum_hydII, Fumarate_lyase, Lyase1_N, Fumarase_C_C
UniProt Accession P07954, B1ANK7
Gene-Disease Assocation FUMARASE DEFICIENCY, HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; HLRCC
Search EB-eye ENSG00000091483
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-GEOD-6573, E-GEOD-3526, E-MTAB-62, ... (30 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-3860, E-GEOD-17482, E-GEOD-5258, E-GEOD-19639, E-GEOD-19397, ... (40 experiments)

Factor Value U/D Experiments
K562
3
E-MTAB-37, E-GEOD-24147, E-GEOD-96
MCF-7
3
E-GEOD-19639, E-GEOD-3529, E-GEOD-20081
Jurkat
2
E-MEXP-2197, E-GEOD-1880
MDA468
2
E-MEXP-440, E-MTAB-62
MOLT4
2
E-MTAB-62, E-MTAB-37
PC3
2
E-GEOD-5258, E-MEXP-2034
447 more value(s).


Cell type

studied in E-GEOD-21668, E-GEOD-3920, E-MEXP-750, E-GEOD-20677, E-GEOD-2822, ... (52 experiments)

Factor Value U/D Experiments
2
2
E-TABM-145, E-TABM-130
721 B lymphoblast
2
E-AFMX-5, E-TABM-145
embryonic stem cell
2
E-MEXP-930, E-GEOD-26672
CD4+ T cell
2
3
E-GEOD-16190, E-MTAB-24, E-AFMX-5, E-MTAB-25, E-TABM-145 ... (5 experiments)
fibroblast
1
2
E-GEOD-3920, E-GEOD-26672, E-GEOD-3204
macrophage
1
2
E-GEOD-3982, E-GEOD-8286, E-GEOD-360
97 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-1577, E-TABM-15, E-MEXP-2280, ... (70 experiments)

Factor Value U/D Experiments
lung adenocarcinoma
1
3
E-GEOD-2514, E-MTAB-37, E-MEXP-231, E-MTAB-62
prostate carcinoma
1
3
E-GEOD-96, E-MEXP-2034, E-MTAB-62, E-MEXP-1327
ischemic cardiomyopathy
2
E-GEOD-1145, E-MTAB-62
sarcoma
2
E-MTAB-62, E-MTAB-37
Huntington's disease
2
E-AFMX-6, E-GEOD-3790
breast carcinoma
2
E-TABM-276, E-MTAB-37
244 more value(s).


Compound treatment

studied in E-GEOD-1615, E-GEOD-7400, E-GEOD-5741, E-TABM-782, E-GEOD-5824, ... (28 experiments)

Factor Value U/D Experiments
ethanol
2
E-MEXP-2241, E-GEOD-3113
lipopolysaccharide
2
E-TABM-868, E-MEXP-1958
none
5
6
E-GEOD-5824, E-TABM-868, E-MEXP-1958, E-MEXP-1601, E-GEOD-412, ... (11 experiments)
unknown
1
E-GEOD-7307
HMB-PP (phosphoantigen)
1
E-MEXP-1601
Cxcl12
1
1
E-GEOD-7307
31 more value(s).


Age at diagnosis

studied in E-GEOD-21653

Factor Value U/D Experiments
31
1
1
E-GEOD-21653


Agent
studied in E-GEOD-19519

Biosource provider
studied in E-TABM-325, E-MTAB-37, E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

cd1a
studied in E-GEOD-22601

cd3
studied in E-GEOD-22601

Cell treatment
studied in E-MEXP-1192

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-GEOD-22097, E-GEOD-19743, E-GEOD-7967, E-TABM-125, E-GEOD-21374, ... (9 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-17189, E-GEOD-6710, E-MEXP-1251, ... (9 experiments)

Clinical treatment
studied in E-GEOD-2171, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

crosslinker and crosslinking wavelength
studied in E-GEOD-21918

Developmental stage
studied in E-GEOD-19743, E-GEOD-1614, E-GEOD-20033, E-GEOD-4667, E-MTAB-62 ... (5 experiments)

Disease staging
studied in E-GEOD-1323, E-GEOD-19743, E-GEOD-22148, E-TABM-147, E-GEOD-21138, ... (7 experiments)

double amplification
studied in E-GEOD-22601

Environmental stress
studied in E-GEOD-1643

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-1643, E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-GEOD-7578, E-GEOD-17385, E-GEOD-20847, ... (7 experiments)

Genotype
studied in E-GEOD-2152, E-TABM-1029, E-GEOD-17476, E-MEXP-421, E-GEOD-22593, ... (12 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-MEXP-1220, E-GEOD-6432, E-GEOD-5681, E-TABM-127, ... (12 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276, E-GEOD-20194, E-GEOD-16716

immunoprecipitated protein
studied in E-GEOD-21918

Individual
studied in E-TABM-325, E-MTAB-197, E-MEXP-2069, E-GEOD-16363, E-GEOD-430, ... (33 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-2405, E-GEOD-12108, E-GEOD-12254, E-MEXP-561, ... (7 experiments)

Injury
studied in E-GEOD-19743

Irradiate
studied in E-GEOD-1977, E-MEXP-2177

Ki67 ihc
studied in E-GEOD-21653

Labeling
studied in E-LGCL-5

Light
studied in E-GEOD-1725

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-7540, E-AFMX-1, E-GEOD-426, E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

P53 ihc
studied in E-GEOD-21653

Performer
studied in E-LGCL-5

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-19703, E-GEOD-1309, E-GEOD-21750, E-GEOD-1460, E-GEOD-17636 ... (5 experiments)

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246, ... (6 experiments)

pt
studied in E-GEOD-21653

Replicate
studied in E-GEOD-18791, E-GEOD-10896

Rna integrity
studied in E-TABM-325

RNAi
studied in E-MEXP-2115, E-GEOD-12438, E-MEXP-1509, E-MEXP-101, E-GEOD-3697, ... (8 experiments)

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-MEXP-70, E-GEOD-17400

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-1643, E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11886, E-GEOD-11428

Strain or line
studied in E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

targeted_cell_type
studied in E-MEXP-70

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-22369, E-GEOD-33562, E-GEOD-22368, E-MEXP-973, E-GEOD-19246, ... (8 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments 99 146
studied in E-GEOD-20194, E-GEOD-16716

Ttf
studied in E-GEOD-21521

Tumor grading
studied in E-GEOD-4922

weight of protein recovered
studied in E-GEOD-21918

Processing time: 0.461 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM